Talk to your doctor about the risks of receiving aripiprazole extended-release injection.Īripiprazole extended-release injection come as a powder to be mixed with water (Abilify Maintena) and as a suspension (liquid) (Aristada, Aristada Initio) to be injected into a muscle by a healthcare provider.Īripiprazole extended-release injection (Abilify Maintena) is usually given once every 4 weeks. You can also visit the Food and Drug Administration (FDA) website () or the manufacturer's website to obtain the Medication Guide. Read the information carefully and ask your doctor or pharmacist if you have any questions. Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with aripiprazole extended-release injection and each time you receive an injection. For more information visit the FDA website. Talk to the doctor who prescribed this medication if you, a family member, or someone you care for has dementia and is receiving aripiprazole. Older adults with dementia may also have a greater chance of having a stroke or ministroke during treatment with antipsychotics.Īripiprazole extended-release (long-acting) injection is not approved by the Food and Drug Administration (FDA) for the treatment of behavior disorders in older adults with dementia. Studies have shown that older adults with dementia (a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities and that may cause changes in mood and personality) who take or receive antipsychotics (medications for mental illness) such as aripiprazole have an increased chance of death during treatment.
0 kommentar(er)
